Rivaroxaban use during vitamin K1 therapy for rodenticide poisoning
This case demonstrates the feasibility of resuming DOAC therapy during VK<sub>1</sub> treatment after LAAR poisoning.
Authors
- Laurent Bertoletti (ORCID: https://orcid.org/0000-0001-8214-3010)
- Brigitte Tardy
- Jean Escal (ORCID: https://orcid.org/0000-0001-7348-418X)
- Xavier Delavenne (ORCID: https://orcid.org/0000-0001-7134-0713)
- Géraldine Poénou (ORCID: https://orcid.org/0000-0001-8020-9215)
- Pauline Noyel
- Angélique Drague
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Nationale d'Ingénieurs de Saint-Étienne (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Société Française de Médecine Vasculaire (FR)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.103273
- Primary Topic
- Animal Ecology and Behavior Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00